雷诺拉嗪联合地尔硫对稳定性心绞痛的疗效评价  

Effect of ranolazin and dihiazem on patients with stable angina pectoris

作　　者：田才林 刘岳怀[2] 

机构地区：[1]浙江省平湖市第二人民医院心内科,浙江平湖314200 [2]浙江大学医学院附属第二医院心内科,浙江杭州310009

出　　处：《中国现代医生》2012年第5期122-123,共2页China Modern Doctor

摘　　要：目的探讨雷诺拉嗪联合地尔硫治疗稳定性心绞痛的临床疗效和安全性。方法 86例稳定性心绞痛患者随机分为观察组49例和对照组37例,对照组给予地尔硫治疗,观察组在此基础上加用雷诺拉嗪。结果观察组临床总有效率和心电图总有效率分别为89.80%和87.76%,对照组临床总有效率和心电图总有效率为83.78%和83.78%,差异具有统计学意义(P<0.05)。两组均无不良反应发生。结论雷诺拉嗪联合地尔硫治疗稳定性心绞痛疗效确切、副作用少、使用安全、值得推广使用。Objective To explore the therapeutic effect and security of ranolazin and dihiazem on patients with stable angi- na pectoris. Methods All of 86 patients with stable angina pectoris were randomly divided into observtion group （49 cases） and control group （37 cases）. The control group was given dihiazem, and the observtion group was given dihiazem and ra- nolazin. Results The clinical and electrocardiographic total effective rate were 89.80% and 87.76% of the observtion group, compared with 83.78% and 83.78% of the control group.It was better.There was a evident difference between the groups（/~ 〈 0.05）. There were not any adverse effect in the tow groups. Conclusion It is accurate,safe to treat stable angina peetoris with ranolazin and dihiazem, and it is worth spreading clincally.

关 键 词：雷诺拉嗪 地尔硫卓 稳定性心绞痛 

分 类 号：R541.4[医药卫生—心血管疾病]